Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
US6071531A · kind A · utility
36Cited by
24References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 28, 1999 |
| Grant date | Jun 6, 2000 |
| Priority date | — |
| Expiry date | Jun 28, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for preventing ovulation in a woman are provided, as well as compositions and methods for female hormone replacement therapy. The compositions can be administered by the use of a transdermal patch. The patch will administer 17-deacetyl norgestimate alone or in combination with an estrogen such as ethinyl estradiol to women.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.